Presidential Determination Raises FY2026 Refugee Ceiling to 17,500 for Afrikaners from South Africa
Presidential Determination No. 2026-14, signed May 21, 2026, raises the Fiscal Year 2026 refugee admissions ceiling from 7,500 to 17,500 to admit Afrikaners from South Africa. The increase responds to what the determination calls an emergency refugee situation involving racially motivated violence in South Africa. The determination was published in the Federal Register on May 27, 2026.
Key points
- The Fiscal Year 2026 refugee admissions ceiling is raised from 7,500, set under PD 2025-13, to 17,500.
- The additional 10,000 admissions are allocated to Afrikaners from South Africa, consistent with Executive Order 14204.
- The President cites increased incitement of racially motivated violence by the South African government and political leaders, and disruptions to U.S. Refugee Admissions Program operations in South Africa, as the basis for the emergency determination.
- Admissions remain subject to Executive Order 14161, requiring the most stringent identity verification for refugees, and Executive Order 14163, which limits refugee entry to cases the Secretaries of State and Homeland Security jointly determine are in the national interest.
- Afrikaners from South Africa processed under Executive Order 14204 may be considered refugees for admission while still in South Africa, their country of nationality or habitual residence.
- The determination was signed May 21, 2026, and published in the Federal Register on May 27, 2026.
Who is affected
Afrikaners from South Africa seeking refugee resettlement in the United States, and refugee resettlement agencies involved in processing their cases.
What to do
Full text
The complete official text was archived on this site on 2026-10-12. It stays available here even if the source link changes or is removed.
Read the official source ↗ Archived copy (if the original is removed)
This summary was produced with AI from the official announcement. Only the official source is authoritative.